Abstract
摘要
相似文献
1
[CLINICAL ASPECT OF FIBRINOLYSIS].
Orv Hetil. 1963 Aug 25;104:1590-3.
2
THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
Semin Hematol. 1964 Oct;1:401-31.
3
FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
Br J Clin Pract. 1964 Jun;18:343-56.
4
[THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO].
Klin Wochenschr. 1964 Jun 1;42:539-46. doi: 10.1007/BF01486683.
5
ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.
Lancet. 1964 Nov 7;2(7367):990-1. doi: 10.1016/s0140-6736(64)90933-x.
6
FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
Thromb Diath Haemorrh. 1965 Jun 15;13:484-91.
7
[FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
Med Interna (Bucur). 1964 Oct;16:1163-72.
8
THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
Surg Gynecol Obstet. 1964 Jul;119:71-4.
9
[THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS].
Prog Ter Clin. 1963 Oct;17:9-18.
10
EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
Br Med Bull. 1964 Sep;20:233-9. doi: 10.1093/oxfordjournals.bmb.a070338.
Zotero 插件